Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
NexGel Inc Warrant (NXGLW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -91.96% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/24/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.52 | 52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 |
52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.7% | Operating Margin (TTM) -27.69% |
Management Effectiveness
Return on Assets (TTM) -20.77% | Return on Equity (TTM) -60.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6447417 |
Shares Outstanding - | Shares Floating 6447417 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
NexGel Inc Warrant
Company Overview
History and Background
NexGel Inc. is a medical device company focused on developing and commercializing advanced wound care solutions. The company was founded to address unmet needs in the wound healing market with innovative technologies. Significant milestones likely involve product development, clinical trials, regulatory approvals, and market launches. Its evolution is tied to the progress of its proprietary technologies and market adoption.
Core Business Areas
- Advanced Wound Care Technologies: NexGel Inc. focuses on the research, development, and commercialization of novel wound healing technologies. Their primary offerings are designed to accelerate the healing process and improve patient outcomes for various types of wounds.
Leadership and Structure
Information on NexGel Inc.'s specific leadership team and organizational structure is not readily available in public databases for warrants. Typically, such details would be found in company filings or on their official website.
Top Products and Market Share
Key Offerings
- Proprietary Hydrogel Technology: NexGel Inc. leverages its proprietary hydrogel technology for advanced wound dressings. These products are designed for use in various wound types, including chronic, acute, and surgical wounds. Competitors include companies offering traditional and advanced wound care products like 3M, Mu00f6lnlycke Health Care, Smith & Nephew, and Convatec.
Market Dynamics
Industry Overview
The global wound care market is a significant and growing industry, driven by an aging population, increasing prevalence of chronic diseases like diabetes and vascular insufficiency, and advancements in medical technology. The market encompasses a wide range of products, from basic dressings to advanced biological and bio-engineered therapies.
Positioning
NexGel Inc. positions itself as an innovator in the advanced wound care segment, aiming to offer superior healing outcomes through its proprietary hydrogel technology. Its competitive advantage lies in the unique properties and potential efficacy of its patented formulations compared to existing treatments.
Total Addressable Market (TAM)
The global wound care market is valued in the tens of billions of dollars and is projected to continue growing. NexGel Inc. is positioned to capture a portion of this market by addressing specific needs within the advanced wound care segment, particularly for chronic and difficult-to-heal wounds.
Upturn SWOT Analysis
Strengths
- Proprietary hydrogel technology with potential for superior wound healing.
- Focus on a high-growth market segment (advanced wound care).
- Potential for patent protection and intellectual property.
Weaknesses
- Limited operational history and market presence compared to established players.
- Dependence on successful clinical trials and regulatory approvals.
- Potential for significant capital requirements for R&D, manufacturing, and market penetration.
Opportunities
- Growing demand for effective chronic wound management solutions.
- Potential for partnerships with healthcare providers and distributors.
- Expansion into new geographic markets or therapeutic applications.
Threats
- Intense competition from large, established medical device companies.
- Regulatory hurdles and lengthy approval processes.
- Challenges in market adoption and reimbursement policies.
- Technological obsolescence or emergence of superior competing technologies.
Competitors and Market Share
Key Competitors
- 3M (MMM)
- Mu00f6lnlycke Health Care (Private)
- Smith & Nephew (SNN)
- Convatec Group PLC (CTEC)
Competitive Landscape
NexGel Inc. faces a competitive landscape dominated by large, established medical device companies with significant market share, extensive product portfolios, and strong distribution networks. NexGel's advantage lies in its potential for differentiated technology, but it must overcome the established players' brand recognition, customer relationships, and economies of scale.
Growth Trajectory and Initiatives
Historical Growth: Information on the historical growth of NexGel Inc. would be derived from the company's revenue and profit trends, which may not be consistently reported for all periods, especially in its early stages.
Future Projections: Future growth projections for NexGel Inc. would depend on the successful commercialization of its products, market penetration, and expansion strategies. Analyst estimates, if available, would be found in financial research reports.
Recent Initiatives: Recent initiatives would typically involve product development advancements, clinical trial progress, regulatory submissions, strategic partnerships, or new market entries. Specific details would be found in company press releases and SEC filings.
Summary
NexGel Inc. operates in the growing wound care market with a focus on proprietary hydrogel technology. While possessing innovative potential and targeting an unmet need, the company faces significant challenges from established competitors, regulatory hurdles, and the capital intensity of the medical device industry. Its success hinges on effective product commercialization, market adoption, and navigating the competitive landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry knowledge of the wound care market.
- Typical company profiles for medical device startups.
- Assumptions based on the nature of warrants.
Disclaimers:
This JSON output is based on publicly available information and general industry knowledge. Specific financial data for NexGel Inc. and its warrants may be limited or require access to proprietary databases and company filings. Market share data is illustrative and estimates. This analysis is for informational purposes only and does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NexGel Inc Warrant
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com | ||
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.